Edwards Lifesciences Aktie
67,50
EUR
-0,15
EUR
-0,22
%
78,48
USD
-1,48
USD
-1,85
%
Werbung
Edwards Lifesciences Aktie Analyse
16.10.18 | Edwards Lifesciences Underweight | Barclays Capital | |
05.12.12 | Edwards Lifesciences sell | UBS AG | |
15.11.12 | Edwards Lifesciences sell | UBS AG | |
12.04.10 | Edwards Lifesciences verkaufen | Wedbush Morgan Securities Inc. | |
28.07.09 | Edwards Lifesciences underperform | Wedbush Morgan Securities Inc. | |
09.03.07 | Edwards Lifesciences underweight | Morgan Stanley | |
06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
Werbung
|
|||
14.06.05 | Edwards Lifesciences Underperform | First Albany |
Werbung
Werbung